The differential expression of MYC between EBV+ and EBV-negative DLBCL confirmed the aggressive nature of EBV+ DLBCL and implied the significant role of MYC in the occurrence and progression of DLBCL. This evidence concerns the gene MYC and diffuse large B-cell lymphoma.